Pro Share Advisors LLC Relay Therapeutics, Inc. Transaction History

Pro Share Advisors LLC

  • $48.7 Billion
  • Q2 2025

A detailed history of Pro Share Advisors LLC transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Pro Share Advisors LLC holds 33,557 shares of RLAY stock, worth $202,348. This represents 0.0% of its overall portfolio holdings.

Number of Shares
33,557
Previous 34,882 3.8%
Holding current value
$202,348
Previous $91,000 27.47%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 07, 2025
SELL
$2.0 - $3.49 $2,650 - $4,624
-1,325 Reduced 3.8%
33,557 $116,000
Q1 2025

May 08, 2025
SELL
$2.62 - $4.92 $19,173 - $36,004
-7,318 Reduced 17.34%
34,882 $91,000
Q4 2024

Feb 13, 2025
BUY
$4.12 - $6.8 $63,827 - $105,345
15,492 Added 58.01%
42,200 $173,000
Q3 2024

Nov 13, 2024
BUY
$6.23 - $9.51 $36,289 - $55,395
5,825 Added 27.89%
26,708 $189,000
Q2 2024

Aug 13, 2024
SELL
$5.9 - $8.02 $31,452 - $42,754
-5,331 Reduced 20.34%
20,883 $136,000
Q1 2024

May 08, 2024
BUY
$7.5 - $12.07 $25,455 - $40,965
3,394 Added 14.87%
26,214 $217,000
Q4 2023

Feb 14, 2024
BUY
$6.01 - $11.48 $18,673 - $35,668
3,107 Added 15.76%
22,820 $251,000
Q3 2023

Nov 13, 2023
BUY
$8.24 - $12.97 $840 - $1,322
102 Added 0.52%
19,713 $165,000
Q2 2023

Aug 10, 2023
BUY
$9.99 - $18.27 $11,768 - $21,522
1,178 Added 6.39%
19,611 $246,000
Q1 2023

May 11, 2023
SELL
$15.0 - $22.76 $37,755 - $57,286
-2,517 Reduced 12.01%
18,433 $303,000
Q4 2022

Feb 02, 2023
BUY
$14.16 - $24.02 $47,506 - $80,587
3,355 Added 19.07%
20,950 $312,000
Q3 2022

Nov 04, 2022
BUY
$18.07 - $31.37 $9,721 - $16,877
538 Added 3.15%
17,595 $394,000
Q2 2022

Aug 01, 2022
SELL
$13.31 - $34.88 $96,763 - $253,577
-7,270 Reduced 29.88%
17,057 $286,000
Q1 2022

May 10, 2022
SELL
$20.26 - $32.36 $125,064 - $199,758
-6,173 Reduced 20.24%
24,327 $728,000
Q4 2021

Feb 08, 2022
BUY
$26.0 - $37.03 $78,130 - $111,275
3,005 Added 10.93%
30,500 $936,000
Q3 2021

Nov 12, 2021
SELL
$29.75 - $37.99 $127,657 - $163,015
-4,291 Reduced 13.5%
27,495 $867,000
Q2 2021

Aug 13, 2021
BUY
$27.5 - $38.19 $194,700 - $270,385
7,080 Added 28.66%
31,786 $1.16 Million
Q1 2021

May 14, 2021
BUY
$32.52 - $61.53 $120,063 - $227,168
3,692 Added 17.57%
24,706 $854,000
Q4 2020

Feb 09, 2021
BUY
$35.51 - $54.03 $746,207 - $1.14 Million
21,014 New
21,014 $873,000

Others Institutions Holding RLAY

# of Institutions
213
Shares Held
173M
Call Options Held
0
Put Options Held
36.1K
View Full List

About Relay Therapeutics, Inc.

RLAY Quotes by TradingView
  • Ticker RLAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 120,219,000
  • Market Cap $725M
  • Description
  • Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...
More about RLAY
Track This Portfolio

Track Pro Share Advisors LLC Portfolio

Follow Pro Share Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email